Status:
COMPLETED
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)
Lead Sponsor:
Hopital Foch
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study of volatile organic compounds (VOCs) detected in exhaled air is an innovative research area for respiratory diseases. This analysis can be done by the technique of electronic nose, simpler a...
Eligibility Criteria
Inclusion
- Patients infected by SARS-CoV-2 whose medical condition warrants hospitalisation (out of intensive care) for oxygen therapy less or equal to 4 l/min
- Patients must be 18 years of age or older
- Fluent in the French language
- Have signed a consent form
- Being affiliated with healthcare insurance
Exclusion
- Pregnant woman
- Patient deprived of liberty by judicial or administrative decision
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04379154
Start Date
April 14 2020
End Date
June 1 2021
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Foch
Suresnes, France